Original Research

Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway

Chen L, Wang J, Wu J, Zheng Q, Hu J

Drug Design, Development and Therapy 2018, 12:3335-3342

Published Date: 4 October 2018